Brigatinib is a small-molecule compound used as an active pharmaceutical ingredient. It is designed to inhibit specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Brigatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
AP-26113
pharmaceutical raw material
6-methylthioguanine
pharmaceutical raw material
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
pharmaceutical raw material
(S)-3-Aminoquinuclidine dihydrochloride
pharmaceutical raw material
Z944
pharmaceutical raw material
The international HS code for Brigatinib (CAS 1197953-54-0) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
AILRADAXUVEEIR-UHFFFAOYSA-N
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC
Sourcing Brigatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.